Imprint | HUPO HBPP

Imprint

Main HUPO-Human Brain Proteome Project (HBPP) contact point:

Medizinisches Proteom-Center
Universitätsstraße 150
44801 Bochum
Germany
Phone: +49 234 32-24279
Fax: +49 234 32-14496
contact [at] hbpp.org

The HBPP is represented by its steering committee, which can be contacted at the above address.

Editorial oversight for the web presence of the HBPP:

Medizinisches Proteom-Center (MPC, on behalf of the the HBPP's scientific board)
Contact: see above

WWW-Server contact:

Medizinisches Proteom-Center
Medical Bioinformatics
Universitätsstraße 150
44801 Bochum
Germany
Phone: +49 234 32-29288

Legal Notice:

The HBPP holds the copyright of all text, images, and layout of its official web presence, i.e. of all content of the pages within the domain name www.hbpp.org. Copying and altering the contents of any of these pages is permitted only with the expressed permission of the HBPP. Saving and copying of web pages on a personal computer for the purpose of viewing with a browser is permitted.

The HBPP accepts no liability, within the bounds of law, for the content of its web presence or for any third party pages given by links on its pages. The HBPP expressly distances itself from the content of any linked pages and does not consider these pages to be its own.

Newscorner

Award for Prof. Daniel Martins-de-Souza

Serrapilheira Institute is the first private nonprofit institution created to promote science and increase its visibility and impact in Brazil.
Their first call was directed to identify and support the best young researchers in Brazil. According to its President, Dr. Hugo Aguilaniu, they looked for those who are posing the big questions in their fields.

There were almost 2000 submitted projects, from which they selected 65. These will receive R$ 100,000.00 (near US$ 31,000.00) for one year. The Institute will select 10 to 12 out of the 65 to receive R$ 1 million (near US$ 310,000.00) for additional three years.

Daniel Martins-de-Souza, member of the HBPP steering committee, is one of the 65 awardees. His project uses neuroproteomics to understand the molecular basis of schizophrenia and to identify protein biomarkers in patients' blood which could predict antipsychotic response.